Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial. - Fokkens, Wytske J; Bachert, Claus; Hopkins, Claire; Marglani, Osama; Praestgaard, Amy; Nash, Scott; Deniz, Yamo; Rowe, Paul J; Sacks, Harry; Jacob‐Nara, Juby A (Clinical & Translational Immunology, 2024)